NMPA Approval

Valsartan and Hydrochlorothiazide Capsules

Approval Number

国药准字H20080097

Registration Date

October 28, 2022

Previous Approval Numbers

国药准字H20080097

Drug Information

Generic Name

缬沙坦氢氯噻嗪胶囊

Brand Name

平亚舒

Dosage Form

胶囊剂

Strength

每粒含缬沙坦80mg，氢氯噻嗪12.5mg。

Drug Type

化学药品

Registration Date

October 28, 2022

Company Address

重庆市北部新区经开园金渝大道101号

Company Address

重庆市北部新区经开园金渝大道101号

Empowering clinical research with data-driven insights and AI-powered tools.

缬沙坦氢氯噻嗪胶囊 - NMPA 批准文号 | MedPath